Skip navigation
Results 1 - 10 of 13 for RANIBIZUMAB
  1. Ranibizumab is used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye ... to read, drive, or perform other daily activities). Ranibizumab is in a class of medications called vascular ...
  2. ... intravitreal injection; Avastin-intravitreal injection; Bevacizumab-intravitreal injection; Ranibizumab-intravitreal injection; Anti-VEGF medications-intravitreal injection
  3. ... Drug Administration (FDA) approved a promising new drug—ranibizumab (marketed as Lucentis) — for treatment of neovascular agerelated ... second drug is considerably cheaper for patients than ranibizumab. "The good news for patients is that there ...
  4. Clinical Trials for Dry AMD (Macular Degeneration Partnership)  
    ... Lucentis For Dry AMD The clinical trial, Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration (PREVENT) is ... The study will determine whether quarterly injections of Ranibizumab (Lucentis) may prevent eyes with dry AMD from ...
  5. If I Had - Macular Degeneration Video (Insidermedicine)  
    ... well. There’s several drugs that are out there – ranibizumab was tested in large clinical trials and showed ...
  6. National Eye Institute (National Eye Institute)  
    ... on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse at ...
  7. ... For example, in February, the FDA approved Lucentis (ranibizumab) injections to treat diabetic retinopathy in patients with ...
  8. ... which are injected into the eye, are Lucentis (ranibizumab) and Avastin (bevacizumab). Results indicate that the two ...
  9. NIH: Turning Discovery Into Health From the National Institutes of Health (National Institutes of Health) - PDF  
    ... advanced AMD. The most recent FDA-approved drug, ranibizumab injection, blocks vessel leakage and in many cases ...
  10. ... on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse at ...
previous · 1 · 2 · next